Diagnostic test accuracy of the Fungitell serum (1→ 3)-β-d-glucan assay for the diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis

C Prosty, OD Luo, R Khalaf, O Del Corpo… - Clinical Microbiology …, 2024 - Elsevier
Abstract Background The diagnosis of Pneumocystis jirovecii pneumonia (PCP) can be
challenging because of diagnostic tests that are imperfect and/or invasive. The Fungitell …

[HTML][HTML] Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV–A systematic review and network meta …

S Hatzl, F Posch, L Scholz, C Geiger, L Kriegl… - Clinical Microbiology …, 2024 - Elsevier
Background Pneumocystis jirovecii pneumonia (PCP) is a serious opportunistic infection in
people living with HIV (PWH) who have low CD4 counts. Despite its side effects …

The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation

G Casalini, A Giacomelli, S Antinori - The Lancet Microbe, 2024 - thelancet.com
In October, 2022, WHO published the first fungal priority pathogen list, which categorised 19
fungal entities into three priority groups (critical, high, and medium), for prioritisation of …

An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia

A Jaramillo Cartagena, OE Asowata, D Ng… - Journal of Clinical …, 2025 - journals.asm.org
Pneumocystis jirovecii (P. jirovecii) is a fungal pathogen associated with significant morbidity
in immunocompromised patients, including both HIV-and non-HIV-infected patients. The …

Clinical Microbiology Reviews: a 21st century vision

GN Forrest - Clinical Microbiology Reviews, 2024 - journals.asm.org
Clinical Microbiology Reviews (CMR) has spent more than 35 years in the vanguard of
presenting fully formed reviews in microbiology, virology, immunology, public health …

[HTML][HTML] Comparative Efficacy and Safety of Pneumocystis jirovecii Pneumonia Prophylaxis Regimens for People with HIV: A Systematic Review and Network Meta …

C Prosty, K Katergi, M Sorin, MB Rjeily… - Clinical Microbiology …, 2024 - Elsevier
Background Pneumocystis jirovecii pneumonia (PCP) is a common opportunistic infection
among people living with HIV (PLWH), particularly among new and untreated cases. Several …

Diagnostic tests performance in detecting Pneumocystis jirovecii: A systematic review and meta-analysis

L Zhang, C Zheng, Y Sun, X Chen, Y Wang… - European Journal of …, 2025 - Springer
Methods Systematic reviews and meta-analyses were performed. Searches were conducted
in PubMed, Embase, and Web of Science. Original clinical studies reporting sensitivity and …

Pulmonary Immunocompromise in Human Immunodeficiency Virus Disease

EF Attia, E Maleche-Obimbo… - Clinics in Chest …, 2024 - chestmed.theclinics.com
Pulmonary Immunocompromise in Human Immunodeficiency Virus Disease - Clinics in Chest
Medicine Skip to Main Content Skip to Main Menu Advertisement Clinics in Chest Medicine …

Risk factors for identifying pneumocystis pneumonia in pediatric patients

C Zhang, Z Li, X Chen, M Wang, E Yang… - Frontiers in Cellular …, 2024 - frontiersin.org
Objectives This study aimed to identify the risk factors and construct the diagnostic model
associated with pneumocystis pneumonia (PCP) in pediatric patients. Methods This …

A Diagnostic Stewardship Intervention to Improve Utilization of 1, 3 β-D-Glucan Testing at a Single Academic Center: Five-Year Experience

JD Colson, JA Kendall, T Yamamoto… - Open Forum Infectious …, 2024 - academic.oup.com
Abstract Background (1, 3)-β-D-glucan (BDG) testing is one of the noninvasive tests to aid
diagnosis of invasive fungal infections (IFIs). The study results have been heterogenous …